Timothy P. Lynch

AEON Biopharma, Inc.

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 1 buy · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€210k

▼ Sales (1 ops.)

€13k

Latest filing published 21 Aug 2026 for AEON Biopharma, Inc., €210k.

Filing timeline

BuySale

Timothy P. Lynch

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Timothy P. Lynch: trading record in brief

This profile gathers the share dealings of Timothy P. Lynch across 4 companies, led by Bioform Medical Inc, Vaxart, Inc. and AEON Biopharma, Inc. We count 8 filings; the first trade dates from 18 May 2007 and the latest from 19 August 2026.

Market trades split into 1 purchase (€210k) and 1 sale (€13k). Purchases outweigh sales by €197k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. 2026 to date brings 1 purchase and no sales.

The record was last updated on 21 August 2026 with an open-market purchase (€210k) in AEON Biopharma, Inc. Typically, a trade is published a median of 5 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.